Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.850
-0.070 (-1.79%)
At close: Sep 4, 2026, 4:00 PM EDT
3.800
-0.050 (-1.30%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Sana Biotechnology Market Cap
Sana Biotechnology has a market cap or net worth of $1.15 billion as of September 4, 2026. Its market cap has increased by 47.09% in one year.
Market Cap
1.15B
Enterprise Value
1.07B
1-Year Change
47.09%
Ranking
Category
Stock Price
$3.85
ChartMarket Cap Chart
Since the IPO on February 4, 2021, Sana Biotechnology's market cap has decreased from $1.33B to $1.15B, a decrease of -13.02%. That is a compound annual growth rate of -2.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 1.15B | 6.31% |
| Dec 31, 2025 | 1.08B | 197.89% |
| Dec 31, 2024 | 363.93M | -54.75% |
| Dec 29, 2023 | 804.30M | 7.21% |
| Dec 30, 2022 | 750.19M | -73.52% |
| Dec 31, 2021 | 2.83B | 113.84% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MoonLake Immunotherapeutics | 1.28B |
| Jade Biosciences | 1.27B |
| Janux Therapeutics | 1.24B |
| Corvus Pharmaceuticals | 1.21B |
| Monte Rosa Therapeutics | 1.18B |
| Kura Oncology | 1.18B |
| Inventiva | 1.11B |
| Attovia Therapeutics | 1.10B |